美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA075141"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
71993-307-60 71993-307 HUMAN PRESCRIPTION DRUG Orphenadrine Citrate, Aspirin and Caffeine Orphenadrine Citrate, Aspirin and Caffeine TABLET ORAL 20230301 N/A ANDA ANDA075141 Atland Pharmaceuticals, LLC ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE 770 mg/1; 60 mg/1; 50 mg/1 60 TABLET in 1 BOTTLE, PLASTIC (71993-307-60)
61825-305-60 61825-305 HUMAN PRESCRIPTION DRUG Norgesic Orphenadrine Citrate, Aspirin and Caffeine TABLET ORAL 20220516 N/A ANDA ANDA075141 Galt Pharmaceuticals, LLC ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE 385 mg/1; 30 mg/1; 25 mg/1 60 TABLET in 1 BOTTLE, PLASTIC (61825-305-60)
50991-999-06 50991-999 HUMAN PRESCRIPTION DRUG Norgesic Forte Orphenadrine Citrate, Aspirin and Caffeine TABLET, MULTILAYER ORAL 20220328 N/A ANDA ANDA075141 Poly Pharmaceuticals, Inc. ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE 770 mg/1; 60 mg/1; 50 mg/1 6 TABLET, MULTILAYER in 1 CARTON (50991-999-06)
50991-999-60 50991-999 HUMAN PRESCRIPTION DRUG Norgesic Forte Orphenadrine Citrate, Aspirin and Caffeine TABLET, MULTILAYER ORAL 20190401 N/A ANDA ANDA075141 Poly Pharmaceuticals, Inc. ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE 770 mg/1; 60 mg/1; 50 mg/1 60 TABLET, MULTILAYER in 1 BOTTLE (50991-999-60)
71993-304-60 71993-304 HUMAN PRESCRIPTION DRUG Orphenadrine Citrate, Aspirin and Caffeine Orphenadrine Citrate, Aspirin and Caffeine TABLET ORAL 20220318 N/A ANDA ANDA075141 Atland Pharmaceuticals, LLC ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE 385 mg/1; 30 mg/1; 25 mg/1 60 TABLET in 1 BOTTLE, PLASTIC (71993-304-60)
61825-302-60 61825-302 HUMAN PRESCRIPTION DRUG ORPHENGESIC FORTE Orphenadrine Citrate, Aspirin and Caffeine TABLET ORAL 20200608 N/A ANDA ANDA075141 Galt Pharmaceuticals, LLC ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE 770 mg/1; 60 mg/1; 50 mg/1 60 TABLET in 1 BOTTLE, PLASTIC (61825-302-60)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase